Half-year report · Q2
9438.TEDINET S100VRCD
Period2024-10-01 → 2025-03-31
Filed2025-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.9bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥27.7bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.5bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Operating income | ¥1.6bn | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥1.1bn | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.7bn | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.5bn | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.2bn | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.6bn | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.8bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥1.6bn | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥30.7bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥29.7bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥29.2bn | at 2024-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥10.1bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥10.5bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥20.6bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥19.1bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥18.7bn | at 2024-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.2bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.8bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.2bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.8bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥13.7bn | at 2023-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.0bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.1bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥789m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥1.4bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥609m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥770m | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.6bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥928m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥31.87 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.05 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥28.41 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥31.82 | 2024-10-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥43.02 | 2023-10-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥28.41 | 2023-10-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 54.6% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.4% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-03-31 | −¥723m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-03-31 | −¥723m |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-03-31 | −¥1.3bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥8.7bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥8.5bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥108m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥2.0bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥3.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥3.1bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥5m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥87m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥2.9bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥2.3bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥609m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥629m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥904m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥904m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥272m |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥15.6bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥14.9bn |
| —segment total | revenue intersegment | 2024-10-01 → 2025-03-31 | ¥723m |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥3.0bn |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-03-31 | −¥698m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-03-31 | −¥698m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥1.2bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥8.4bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥8.4bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥76m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥2.3bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥2.6bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥2.6bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥4m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥217m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥2.7bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥2.0bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥617m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥37m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥521m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥521m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥157m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥14.2bn |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥13.5bn |
| —segment total | revenue intersegment | 2023-10-01 → 2024-03-31 | ¥698m |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥2.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 541
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)小 此 木 雅 博 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)江 村 羊 奈 子 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 13517857000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 14885366000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 27669161000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 1518201000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 1721600000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 2827217000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 1558786000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 1757226000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 2363920000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 1650335000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 1827614000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 2467909000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 18680537000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 20560441000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 19144770000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 29150244000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 30704607000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 29686449000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 28.41 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 31.87 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 43.05 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | 28.41 | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | 31.82 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 43.02 | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.514 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.546 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.520 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 1241557000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 1974048000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 4131332000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -609226000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -789031000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -1368974000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -928263000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -770349000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -1637433000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 13426899000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 15240841000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 14828744000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 60290800 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 60290800 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 60290800 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 60290800 | |
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 11887500 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.2140 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |